<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03745859</url>
  </required_header>
  <id_info>
    <org_study_id>2018/302</org_study_id>
    <nct_id>NCT03745859</nct_id>
  </id_info>
  <brief_title>Evaluation of a New Open Source Virtual Bronchoscope Navigation System</brief_title>
  <official_title>Fraxinus- Assessment of an Open Source Virtual Bronchoscopic Navigation System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Norwegian University of Science and Technology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>St. Olavs Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>SINTEF Health Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Norwegian University of Science and Technology</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the feasibility of the Fraxinus Virtual Bronchoscope Navigation (VBN) System in
      the bronchoscopic access to target lesions. The study emphasizes the system´s efficacy in
      diagnostics of peripheral pulmonary lesions and the ease of use for the operator.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Multi-center study. The study explores Fraxinus which is an open source, software only,
      simple guiding system for bronchoscopy. The system provides 3D maps with centerline-to-target
      information extracted from preoperative computed tomography. The ability of the system to
      guide a user to a peripheral target lesion will be evaluated. During bronchoscopy any
      established method for diagnostic sampling is allowed. User Evaluation will be essential to
      decide if the Fraxinus VBN System is beneficial in a clinical setting.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 19, 2018</start_date>
  <completion_date type="Anticipated">October 2021</completion_date>
  <primary_completion_date type="Anticipated">October 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Evidence if the Fraxinus VBN System has a role in the assessment of peripheral pulmonary lesions</measure>
    <time_frame>48 hours</time_frame>
    <description>The proportion of cases in which the use of the system is considered beneficial</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Diagnostic yield</measure>
    <time_frame>1 week</time_frame>
    <description>Diagnostic success defined as cytology or biopsy with pathology</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of procedure</measure>
    <time_frame>48 hours</time_frame>
    <description>Time spent with preparations and bronchoscopy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events</measure>
    <time_frame>48 hours</time_frame>
    <description>Procedure related adverse events or unexpected incidents registrated</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Operators-reported satisfaction</measure>
    <time_frame>48 hours</time_frame>
    <description>Enquiry on main operator´s experience after end of bronchoscopy</description>
  </secondary_outcome>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Bronchial Neoplasms</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Fraxinus VBN system</intervention_name>
    <description>Open source planning tool for bronchoscopy</description>
    <other_name>Virtual Bronchoscopic Navigation System</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patents with undiagnosed peripheral pulmonary lesion(s) who have been recommended for
        bronchoscopy
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  referred to thoracic department in any of the participating hospitals with undiagnosed
             peripheral pulmonary lesion(s) not visible by bronchoscopy

          -  voluntary signed an informed consent

        Exclusion Criteria:

          -  pregnancy

          -  Any patient that the Investigator feels is not appropriate for this study for any
             reason
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Hanne Sorger, md phd</last_name>
    <role>Study Director</role>
    <affiliation>Norwegian University of Science and Technology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Arne Kildahl-Andersen, md</last_name>
    <phone>72829988</phone>
    <email>arne.kildahl-andersen@stolav.no</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Håkon O Leira, md phd</last_name>
    <email>hakon.o.leira@ntnu.no</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>St Olavs Hospital</name>
      <address>
        <city>Trondheim</city>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Arne Kildahl-Andersen</last_name>
      <email>arne.kildahl-andersen@stolav.no</email>
    </contact>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>November 15, 2018</study_first_submitted>
  <study_first_submitted_qc>November 15, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 19, 2018</study_first_posted>
  <last_update_submitted>November 27, 2019</last_update_submitted>
  <last_update_submitted_qc>November 27, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 29, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Bronchoscopy</keyword>
  <keyword>Navigation</keyword>
  <keyword>Feasibility Studies</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bronchial Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

